Scientists at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a critical mechanism driving ...

Novo Nordisk reports disappointing results from its trial of GLP-1s for Alzheimer's disease.

in advance of APOE4 Alzheimer's Alliance Webinar discussing the root causes of Alzheimer's. Join the APOE4 Alzheimer's Alliance's free virtual webinar to learn more about Dr. Fortea's research on the ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related dementia (ADRD), sparking hope for potential interventions to prevent the ...

SEATTLE — Alzheimer's disease is more than memory loss. It can slowly take away a person's ability to think, decide, and live independently. It is the most common kind of dementia which causes trouble ...

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of approximately 20% during the ...

Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease that could help protect the brain from damage and preserve cognitive ...

Is there research involving stem cell therapy for those with Alzheimer’s disease? Christopher Duma, M.D., F.A.C.S., president and founder of Regeneration Biomedical, delivered preliminary data from ...

This scan of a mouse brain shows blood vessels (red), brain cells (green), and amyloid plaques (blue). A new gene therapy treatment developed by UC San Diego works by reprogramming the behavior of ...